/RDGL
RDGL Stock - Vivos Inc.
Healthcare|Medical - DevicesOTC
$0.07-0.57%
$0.00 (-0.57%) • Dec 19
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.6
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RDGL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.07 – $0.07
TARGET (TP)$0.08
STOP LOSS$0.06
RISK/REWARD1:1.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.39
52W High$0.17
52W Low$0.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $27,995 | $19,500 | $36,499 | $14,887 | $7,000 |
| Gross Profit | $-2,984 | $-6,036 | $7,720 | $2,887 | $1,392 |
| Gross Margin | -10.7% | -31.0% | 21.2% | 19.4% | 19.9% |
| Operating Income | $-2,604,000 | $-2,793,000 | $-2,518,000 | $-2,502,000 | $-673,000 |
| Net Income | $-2,910,000 | $-2,895,000 | $-2,470,000 | $-2,528,000 | $-957,000 |
| Net Margin | -10394.7% | -14846.2% | -6767.3% | -16981.3% | -13671.4% |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.00 |
Company Overview
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RDGLBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 7, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 13, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 9, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 24, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 9, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 18, 2024 | — | $-0.01 | — | — |
Q4 2023 | Nov 6, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 4, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 4, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 1, 2023 | — | $-0.00 | — | — |
Q4 2022 | Oct 19, 2022 | — | $-0.00 | — | — |
Q3 2022 | Jul 22, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 10, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 7, 2022 | — | $-0.00 | — | — |
Q4 2021 | Oct 25, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 2, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 10, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RDGL
What is RDGL's current stock price?
Vivos Inc. (RDGL) is currently trading at $0.07 per share. The stock has moved -0.57% today.
What is the analyst price target for RDGL?
No analyst price targets are currently available for this stock.
What sector is Vivos Inc. in?
Vivos Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is RDGL's market cap?
Vivos Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does RDGL pay dividends?
No, Vivos Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBLOZF
Cannabix Technologies Inc.
$0.41
Mkt Cap: $0.0B
CBSTF
The Cannabist Company Holdings Inc.
$0.07
Mkt Cap: $0.0B
CYYNF
Cynata Therapeutics Limited
$0.15
Mkt Cap: $0.0B
DSOL
Drug Free Solution, Inc.
$0.00
Mkt Cap: $0.0B
ELXMF
Nova Eye Medical Limited
$0.00
Mkt Cap: $0.0B
MMIRF
MedMira Inc.
$0.05
Mkt Cap: $0.0B
NVYTF
Novacyt S.A.
$0.51
Mkt Cap: $0.0B
PETV
PetVivo Holdings, Inc.
$1.16
Mkt Cap: $0.0B
SEOVF
Sernova Corp.
$0.09
Mkt Cap: $0.0B
TLTFF
Theralase Technologies Inc.
$0.12
Mkt Cap: $0.0B
Explore stocks similar to RDGL for comparison